BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15308433)

  • 1. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction.
    Goldberg A; Hammerman H; Petcherski S; Zdorovyak A; Yalonetsky S; Kapeliovich M; Agmon Y; Markiewicz W; Aronson D
    Am J Med; 2004 Aug; 117(4):242-8. PubMed ID: 15308433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction.
    Goldberg A; Hammerman H; Petcherski S; Nassar M; Zdorovyak A; Yalonetsky S; Kapeliovich M; Agmon Y; Beyar R; Markiewicz W; Aronson D
    Arch Intern Med; 2006 Apr; 166(7):781-6. PubMed ID: 16606816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of admission blood glucose levels on the short term mortality in patients with acute ST-segment elevation myocardial infarction].
    Yang YM; Liu Y; Zhu J; Tan HQ; Liang Y; Li Y; Li JD; Zhang Y; Liu LS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1230-3. PubMed ID: 19595174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction.
    Goldberg A; Hammerman H; Petcherski S; Zdorovyak A; Yalonetsky S; Kapeliovich M; Agmon Y; Markiewicz W; Aronson D
    Am Heart J; 2005 Aug; 150(2):330-7. PubMed ID: 16086939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
    Srinivas VS; Cannon CP; Gibson CM; Antman EM; Greenberg MA; Tanasijevic MJ; Murphy S; de Lemos JA; Sokol S; Braunwald E; Mueller HS
    Am Heart J; 2001 Jul; 142(1):29-36. PubMed ID: 11431653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    Coron Artery Dis; 2009 Jan; 20(1):9-14. PubMed ID: 19050596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.
    Timmer JR; van der Horst IC; Ottervanger JP; Henriques JP; Hoorntje JC; de Boer MJ; Suryapranata H; Zijlstra F;
    Am Heart J; 2004 Sep; 148(3):399-404. PubMed ID: 15389225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of hyponatremia in the acute phase of ST-elevation myocardial infarction as a marker of severity.
    Lazzeri C; Valente S; Chiostri M; Attanà P; Picariello C; Gensini GF
    Am J Cardiol; 2012 Nov; 110(10):1419-24. PubMed ID: 22863175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic value of hyponatremia in patients with acute myocardial infarction].
    Wang LF; Li ZQ; Tang Q; Xu D; Sun XY; Li WM; Fu SY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):243-6. PubMed ID: 16630460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium level on admission and in-hospital outcomes of STEMI patients treated with primary angioplasty: the ANIN Myocardial Infarction Registry.
    Klopotowski M; Kruk M; Przyluski J; Kalinczuk L; Pregowski J; Bekta P; Malek LA; Kepka C; Ciszewski A; Chmielak Z; Demkow M; Karcz M; Witkowski A; Ruzyllo W
    Med Sci Monit; 2009 Sep; 15(9):CR477-83. PubMed ID: 19721399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyponatremia (<135 mEq/L) on outcome in patients with non-ST-elevation acute coronary syndrome.
    Singla I; Zahid M; Good CB; Macioce A; Sonel AF
    Am J Cardiol; 2007 Aug; 100(3):406-8. PubMed ID: 17659918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
    Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
    Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
    Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
    Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
    Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
    Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Hoebers LP; Damman P; Claessen BE; Vis MM; Baan J; van Straalen JP; Fischer J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am J Cardiol; 2012 Jan; 109(1):53-9. PubMed ID: 21944676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of lead aVR in patients with a first non-ST-segment elevation acute myocardial infarction.
    Barrabés JA; Figueras J; Moure C; Cortadellas J; Soler-Soler J
    Circulation; 2003 Aug; 108(7):814-9. PubMed ID: 12885742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.